Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Net Income (2016 - 2025)

Historic Net Income for Icu Medical (ICUI) over the last 17 years, with Q3 2025 value amounting to -$1.9 million.

  • Icu Medical's Net Income rose 9437.59% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.7 million, marking a year-over-year increase of 9220.05%. This contributed to the annual value of -$117.7 million for FY2024, which is 29685.72% down from last year.
  • Latest data reveals that Icu Medical reported Net Income of -$1.9 million as of Q3 2025, which was up 9437.59% from $32.5 million recorded in Q2 2025.
  • Icu Medical's Net Income's 5-year high stood at $32.5 million during Q2 2025, with a 5-year trough of -$39.5 million in Q1 2024.
  • For the 5-year period, Icu Medical's Net Income averaged around -$5.4 million, with its median value being -$9.9 million (2023).
  • Its Net Income has fluctuated over the past 5 years, first crashed by 55569.22% in 2024, then soared by 25183.13% in 2025.
  • Over the past 5 years, Icu Medical's Net Income (Quarter) stood at $19.9 million in 2021, then plummeted by 177.97% to -$15.5 million in 2022, then dropped by 10.37% to -$17.1 million in 2023, then plummeted by 38.96% to -$23.8 million in 2024, then surged by 92.22% to -$1.9 million in 2025.
  • Its Net Income stands at -$1.9 million for Q3 2025, versus $32.5 million for Q2 2025 and -$15.5 million for Q1 2025.